|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> 阿曲生坦>> 市场分析报告 |
阿曲生坦市场分析报告 |
|
Atrasentan hydrochloride (CAS 195733-43-8) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Atrasentan hydrochloride Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Global Market Report of Atrasentan (CAS 173937-91-2) December 2024 Global Market Report of Atrasentan hydrochloride (CAS 195733-43-8) December 2024 CAS 173937-91-2 Atrasentan Chemical Report & Database ... Report & Database definitions: Name: Atrasentan: Atrasentan; (2R,3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine ... : Chemical or Reaction Intermediate The Atrasentan Report & Database gives Market Consumption ... CAS 195733-43-8 Atrasentan hydrochloride Chemical Report & Database ... Report & Database definitions: Name: Atrasentan hydrochloride: Atrasentan-hydrochloride; (2R,3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl ... : Chemical or Reaction Intermediate The Atrasentan hydrochloride Report & Database gives Market ... IgA Nephropathy- Pipeline Insight, 2021 ... IgA Nephropathy Emerging Drugs Atrasentan: Chinook Therapeutics Atrasentan is a potent and selective ... initiate a phase 3 trial (ALIGN) of Atrasentan in early 2021 in patients with ... Pharmaceuticals, Inc. Key Products Atrasentan LNP023 Nefecon Sparsentan BION ... Endothelin Receptor Antagonist - Pipeline Insight, 2022 ... the treatment of Resistant hypertension. Atrasentan: Chinook Therapeutics Atrasentan is a highly potent and selective ... Pharmazz Key Products Aprocitentan Sparsentan Atrasentan Bosentan Macitentan Getagozumab Ambrisentan Sovateltide ... Type2 Diabetes Mellitus- Pipeline Insight, 2022 ... /Metoprolol Ruboxistaurin Mesylate BMS-816336 Atrasentan Inhaled Human Insulin Human regular ... Alport Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major Alport syndrome markets are expected to exhibit a CAGR of 3.46% during 2024-2034. The Alport syndrome market has been comprehensively analyzed in IMARC's new report titled "Alport Syndrome Market: Epidemiology, Industry Trends, Share, Size, ... Focal Segmental Glomerulosclerosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major focal segmental glomerulosclerosis markets reached a value of US$ 332.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 578.0 Million by 2034, exhibiting a growth rate (CAGR) of 5.15% during 2024-2034. The focal ... IgA Nephropathy Market - A Global and Regional Analysis: Focus on Regional Analysis - Analysis and Forecast, 2025-2035 ... accelerated approval for Novartis’ Vanrafia (atrasentan) for the treatment of primary immunoglobulin ... Global IgA Nephropathy Treatment Market - 2025-2033 ... accelerated approval for Vanrafia (atrasentan), developed by Novartis AG. Atrasentan is a novel first-in-class drug ... Piperonal Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type ... of Tadalafil, Stiripentol, Droxidopa, L-Dopa, and Atrasentan, among other important medications. This ... Alport Syndrome Market - A Global and Regional Analysis: Focus on Region and Country Analysis - Analysis and Forecast, 2025-2035 ... clinical trial, which demonstrated that atrasentan effectively reduced proteinuria in patients with ... |